今日上海
新冠中和抗体在上海完成Ⅰ期临床给药 - 2020年07月14日
Coronavirus antibody treatment shows promising results
Phase 1 clinical trials on a homegrown neutralizing antibody treatment for the novel coronavirus have completed in Shanghai.
The new drug, JS016, was given to 40 healthy volunteers through venous injection. The trials are the first of their kind to test neutralizing antibody treatment against the coronavirus in uninfected people.
The trials showed JS016 has good safety and tolerability for human use.
